These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34367063)

  • 41. [Level at which control objectives are reached in patients in different population groups with type 2 diabetes].
    Herrero A; Pinillos J; Sabio P; Martín JL; Garzón G; Gil Á
    Semergen; 2017; 43(8):550-556. PubMed ID: 27889132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
    Ueki K; Sasako T; Okazaki Y; Kato M; Okahata S; Katsuyama H; Haraguchi M; Morita A; Ohashi K; Hara K; Morise A; Izumi K; Ishizuka N; Ohashi Y; Noda M; Kadowaki T;
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):951-964. PubMed ID: 29079252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is there an association between non-dipping blood pressure and measures of glucose variability in type 1 diabetes?
    Jaiswal M; Ang L; Mizokami-Stout K; Pop-Busui R
    J Diabetes Complications; 2018 Oct; 32(10):947-950. PubMed ID: 30087063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of macrovascular and microvascular complications in Type 2 diabetes: results of longitudinal study design.
    Nazimek-Siewniak B; Moczulski D; Grzeszczak W
    J Diabetes Complications; 2002; 16(4):271-6. PubMed ID: 12126785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II.
    Paisey RB; Arredondo G; Villalobos A; Lozano O; Guevara L; Kelly S
    Diabetes Care; 1984; 7(5):428-33. PubMed ID: 6499636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intensive versus standard multifactorial cardiovascular risk factor control in screen-detected type 2 diabetes: 5-year and longer-term modelled outcomes of the ADDITION-Leicester study.
    Webb D; Dales J; Zaccardi F; Hill S; Moore C; Farooqi A; Griffin S; Davies M; Khunti K
    Diabetes Metab Res Rev; 2019 Mar; 35(3):e3111. PubMed ID: 30521699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Factors predictive of cardiovascular disease in patients with type-2 diabetes and hypercholesterolemia. ESODIAH study].
    Pintó X; Corbella E; Figueras R; Biarnés J; Ricart W; Morales C; Falkon L; Masana L;
    Rev Esp Cardiol; 2007 Mar; 60(3):251-8. PubMed ID: 17394870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Chronic complications of type 2 diabetes mellitus. Clinical course after 5 years of follow-up].
    Mundet Tudurí X; Carmona Jiménez F; Gussinyer Canabal P; Tapia Mayor I; García Villena I; Farrús Palou M; Romea Lecumberri S
    Aten Primaria; 2000 Apr; 25(6):405-11. PubMed ID: 10857231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal.
    Zehra Manjee K; Hassan D
    Rev Port Cardiol; 2024 May; 43(5):299-300. PubMed ID: 37923245
    [No Abstract]   [Full Text] [Related]  

  • 51. [Strokein type 2 diabetic patients in the internal medicine department of the Teaching Hospital of Point G].
    Traoré D; Sy D; Sangaré M; Keita K; Konaté M; Sow DS; Nyanke RN; Mariko M; Mariko ML; Koné N; Malle M; Sangaré BB; Dembélé IA; Cissoko M; Soukho AK; Traore AK
    Mali Med; 2022; 37(1):29-31. PubMed ID: 38196257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk Factors for Diabetes and Cardiovascular Complications in the Chinese Population.
    Dou C; Liu D; Wang T
    China CDC Wkly; 2023 Nov; 5(45):1017-1021. PubMed ID: 38020345
    [No Abstract]   [Full Text] [Related]  

  • 53. Update on prevention of diabetic foot ulcer.
    Miranda C; Da Ros R; Marfella R
    Arch Med Sci Atheroscler Dis; 2021; 6():e123-e131. PubMed ID: 34381913
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of peripheral white blood cell counts in the association between central adiposity and glycemic status.
    Liu F; Li Y; Li W; Feng R; Zhao H; Chen J; Du S; Ye W
    Nutr Diabetes; 2024 May; 14(1):30. PubMed ID: 38760348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular mechanism and intervention measures of microvascular complications in diabetes.
    Xu R; Fang Z; Wang H; Gu Y; Yu L; Zhang B; Xu J
    Open Med (Wars); 2024; 19(1):20230894. PubMed ID: 38645437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gaps of Medication Treatment Management Between Guidelines and Real-World for Inpatients With Type 2 Diabetes in China From Pharmacist's Perspective.
    Song ZH; Wang XL; Wang XF; Liu J; Luo SQ; Xu SS; Cheng X; Bai J; Dong LM; Zhang C; Zhou JB
    Front Endocrinol (Lausanne); 2022; 13():900114. PubMed ID: 35707460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tandem mass tag-based serum proteomic profiling revealed diabetic foot ulcer pathogenesis and potential therapeutic targets.
    Yu XT; Wang F; Ding JT; Cai B; Xing JJ; Guo GH; Guo F
    Bioengineered; 2022 Feb; 13(2):3171-3182. PubMed ID: 35068329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular Risk Factor Status in Hospitalized Patients With Type 2 Diabetes in China.
    Yang X; Liu Q; Fan Y; Ding L; Wang R; Hu G; Liu M
    Front Endocrinol (Lausanne); 2021; 12():664183. PubMed ID: 34367063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
    Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
    Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Racial disparities in cardiovascular risk factor control in an underinsured population with Type 2 diabetes.
    Wang Y; Katzmarzyk PT; Horswell R; Zhao W; Li W; Johnson J; Ryan DH; Hu G
    Diabet Med; 2014 Oct; 31(10):1230-6. PubMed ID: 24750373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.